Sanofi

Sanofi, GSK received a nod to test the phase 3 Covid-19 vaccine candidate in India

New Delhi: Sanofi and GSK have received approval for their phase 3 clinical studies in India to assess safety, efficacy,…

3 years ago

Another Covid-19 vaccine Moves final trials

PARIS: Generation of the following possible vaccine from Covid-19 will start within fourteen days, its programmers Sanofi and GlaxoSmithKline said…

3 years ago